Yggdrasil Medical A/S — Credit Rating and Financial Key Figures
CVR number: 41796510
Vesterhavsgade 147, 6700 Esbjerg
Income statement (kDKK)
2021 | 2022 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 1 400.00 | - 269.35 |
| Employee benefit expenses | - 492.00 | -17.06 |
| Total depreciation | - 595.00 | |
| EBIT | 313.00 | - 286.41 |
| Other financial income | 4.00 | -0.02 |
| Other financial expenses | -33.00 | -44.82 |
| Pre-tax profit | 284.00 | - 331.25 |
| Income taxes | - 171.00 | |
| Net earnings | 113.00 | - 331.25 |
Assets (kDKK)
2021 | 2022 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Non-current other receivables | 33.00 | |
| Long term receivables total | 33.00 | |
| Raw materials and consumables | 50.00 | |
| Finished products/goods | 42.00 | |
| Inventories total | 92.00 | |
| Current trade debtors | 517.00 | 34.94 |
| Current other receivables | 18.18 | |
| Current deferred tax assets | 109.60 | |
| Short term receivables total | 517.00 | 162.72 |
| Cash and bank deposits | 2 221.00 | 1 721.73 |
| Cash and cash equivalents | 2 221.00 | 1 721.73 |
| Balance sheet total (assets) | 2 863.00 | 1 884.45 |
Equity and liabilities (kDKK)
2021 | 2022 | |
|---|---|---|
| Share capital | 400.00 | 400.00 |
| Share premium account | 793.00 | 793.15 |
| Retained earnings | 112.67 | |
| Profit of the financial year | 113.00 | - 331.25 |
| Shareholders equity total | 1 306.00 | 974.57 |
| Non-current liabilities total | ||
| Current trade creditors | 1 078.00 | 610.45 |
| Short-term deferred tax liabilities | 171.00 | |
| Other non-interest bearing current liabilities | 308.00 | 299.43 |
| Current liabilities total | 1 557.00 | 909.88 |
| Balance sheet total (liabilities) | 2 863.00 | 1 884.45 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.